Cargando…

Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives

Patients with inflammatory bowel disease (IBD) face an increased lifetime risk of developing colorectal cancer (CRC). Independent factors associated with increased risk include long disease duration, extensive colonic involvement, young age at onset of IBD, severity of inflammation, primary sclerosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stolfi, Carmine, Pallone, Francesco, Monteleone, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373216/ https://www.ncbi.nlm.nih.gov/pubmed/22701310 http://dx.doi.org/10.1155/2012/980458

Ejemplares similares

Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer
por: Stolfi, Carmine, et al.
Publicado: (2013)

Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer
por: Stolfi, Carmine, et al.
Publicado: (2012)

Role of T(H)17 cytokines in the control of colorectal cancer
por: De Simone, Veronica, et al.
Publicado: (2013)

The Dual Role of Inflammation in Colon Carcinogenesis
por: Monteleone, Giovanni, et al.
Publicado: (2012)

The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis
por: Stolfi, Carmine, et al.
Publicado: (2013)

Interleukin-21 in cancer immunotherapy: Friend or foe?
por: Stolfi, Carmine, et al.
Publicado: (2012)

Association Between Celiac Disease and Cancer
por: Marafini, Irene, et al.
Publicado: (2020)

Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer
por: Słoka, Joanna, et al.
Publicado: (2023)

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
por: Laudisi, Federica, et al.
Publicado: (2018)

Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
por: Troncone, Edoardo, et al.
Publicado: (2021)

Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
por: Stolfi, Carmine, et al.
Publicado: (2020)

Impact of Food Additives on Gut Homeostasis
por: Laudisi, Federica, et al.
Publicado: (2019)

Smad7 as a positive regulator of intestinal inflammatory diseases
por: Monteleone, Giovanni, et al.
Publicado: (2023)

Th17-related cytokines: new players in the control of chronic intestinal inflammation
por: Monteleone, Ivan, et al.
Publicado: (2011)

Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
por: Di Grazia, Antonio, et al.
Publicado: (2020)

Interleukin-23 and Th17 Cells in the Control of Gut Inflammation
por: Monteleone, Ivan, et al.
Publicado: (2009)

Role of Interleukin-34 in Cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms
por: Salvatori, Silvia, et al.
Publicado: (2023)

Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials
por: Monteleone, Giovanni, et al.
Publicado: (2022)

Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders?
por: Marônek, Martin, et al.
Publicado: (2020)

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
por: Stolfi, Carmine, et al.
Publicado: (2022)

Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier
por: Stolfi, Carmine, et al.
Publicado: (2023)

Anthelmintic Drugs as Emerging Immune Modulators in Cancer
por: Stolfi, Carmine, et al.
Publicado: (2023)

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
por: Laudisi, Federica, et al.
Publicado: (2020)

Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance
por: Monteleone, Giovanni, et al.
Publicado: (2023)

Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
por: Troncone, Edoardo, et al.
Publicado: (2018)

Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
por: Stolfi, Carmine, et al.
Publicado: (2011)

Lesional Accumulation of CD163-Expressing Cells in the Gut of Patients with Inflammatory Bowel Disease
por: Franzè, Eleonora, et al.
Publicado: (2013)

Chemoprevention of Colorectal Cancer by Dietary Compounds
por: Costea, Teodora, et al.
Publicado: (2018)

Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
por: Manzano, A., et al.
Publicado: (2012)

Colorectal cancer chemoprevention: is aspirin still in the game?
por: Grancher, Adrien, et al.
Publicado: (2022)

Dietary derived compounds in cancer chemoprevention
por: Langner, Ewa, et al.
Publicado: (2012)

Chemoprevention of colorectal cancer: Past, present, and future
por: Umezawa, Shotaro, et al.
Publicado: (2019)

Progranulin sustains STAT3 hyper‐activation and oncogenic function in colorectal cancer cells
por: Laudisi, Federica, et al.
Publicado: (2019)

Mesalazine-induced renal calculi
por: Jacobsson, Henrik, et al.
Publicado: (2013)

Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer
por: Wang, Shi-Tong, et al.
Publicado: (2020)

Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention
por: Li, Wenqian, et al.
Publicado: (2022)

Colorectal Cancer Chemoprevention: A Dream Coming True?
por: Lepore Signorile, Martina, et al.
Publicado: (2023)

An Overview of the Role of Innate Lymphoid Cells in Gut Infections and Inflammation
por: Sedda, Silvia, et al.
Publicado: (2014)

Development of an Inflammation-Associated Colorectal Cancer Model and Its Application for Research on Carcinogenesis and Chemoprevention
por: Tanaka, Takuji
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_adi7k3r0vun2upr35p0lalrjck